Evidence map›Paper›PMID 39650072›Full record

ReviewBio-design and manufacturing2024

Biofabrication and biomanufacturing in Ireland and the UK.

Jack F Murphy, Martha Lavelle, Lisa Asciak, Ross Burdis, Hannah J Levis, Cosimo Ligorio, Jamie McGuire, Marlene Polleres, Poppy O Smith, Lucinda Tullie and 15 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Bio-design and manufacturing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Extrusion bioprinting: meeting the promise of human tissue biofabrication?Progress in biomedical engineering (Bristol, England) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Jack F MurphyDepartment of Engineering, University of Cambridge, Cambridge, CB2 1PZ UK.ORCID 0000-0002-0417-7298
Martha LavelleDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS1 3NY UK.
Lisa AsciakDepartment of Biomedical Engineering, University of Strathclyde, Glasgow, G4 0NW UK.
Ross BurdisDepartment of Materials, Institute of Biomedical Engineering, Imperial College London, London, SW7 2AZ UK.ORCID 0000-0001-8888-9251
Hannah J LevisDepartment of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, L7 8TX UK.ORCID 0000-0002-3923-1178
Cosimo LigorioBiodiscovery Institute, University of Nottingham, Nottingham, NG7 2RD UK.
Jamie McGuireCentre for Human Development, Stem Cells and Regeneration, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, S016 6YD UK.
Marlene PolleresDivision of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT UK.
Poppy O SmithUCL Centre for Nerve Engineering, Department of Pharmacology, UCL School of Pharmacy, University College London, London, WC1N 1AX UK.ORCID 0000-0002-3325-5400
Lucinda TullieStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, NW1 1AT UK.ORCID 0000-0001-5679-7504
Juan Uribe-GomezCÚRAM, SFI Research Centre for Medical Devices, University of Galway, Galway, H91 W2TY Ireland.
Biqiong ChenSchool of Mechanical and Aerospace Engineering, Queen's University Belfast, Belfast, BT9 5AH UK.ORCID 0000-0002-6465-2871
Jonathan I DawsonCentre for Human Development, Stem Cells and Regeneration, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, S016 6YD UK.
Julien E GautrotSchool of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS UK.
Nigel M HooperDivision of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT UK.
Daniel J KellyTrinity Centre for Biomedical Engineering, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Vivian S W LiStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, NW1 1AT UK.ORCID 0000-0003-2041-0085
Alvaro MataBiodiscovery Institute, University of Nottingham, Nottingham, NG7 2RD UK.
Abhay PanditCÚRAM, SFI Research Centre for Medical Devices, University of Galway, Galway, H91 W2TY Ireland.
James B PhillipsUCL Centre for Nerve Engineering, Department of Pharmacology, UCL School of Pharmacy, University College London, London, WC1N 1AX UK.ORCID 0000-0001-8117-3074
Wenmiao ShuDepartment of Biomedical Engineering, University of Strathclyde, Glasgow, G4 0NW UK.
Molly M StevensDepartment of Materials, Institute of Biomedical Engineering, Imperial College London, London, SW7 2AZ UK.ORCID 0000-0002-7335-266X
Rachel L WilliamsDepartment of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, L7 8TX UK.ORCID 0000-0002-1954-0256
James P K ArmstrongDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS1 3NY UK.ORCID 0000-0002-0599-0643
Yan Yan Shery HuangDepartment of Engineering, University of Cambridge, Cambridge, CB2 1PZ UK.ORCID 0000-0003-2619-730X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As we navigate the transition from the Fourth to the Fifth Industrial Revolution, the emerging fields of biomanufacturing and biofabrication are transforming life sciences and healthcare. These sectors are benefiting from a synergy of synthetic and engineering biology, sustainable manufacturing, and integrated design principles. Advanced techniques such as 3D bioprinting, tissue engineering, directed assembly, and self-assembly are instrumental in creating biomimetic scaffolds, tissues, organoids, medical devices, and biohybrid systems. The field of biofabrication in the United Kingdom and Ireland is emerging as a pivotal force in bioscience and healthcare, propelled by cutting-edge research and development. Concentrating on the production of biologically functional products for use in drug delivery, in vitro models, and tissue engineering, research institutions across these regions are dedicated to innovating healthcare solutions that adhere to ethical standards while prioritising sustainability, affordability, and healthcare system benefits. Graphic abstract:

Indexed as

BiohybridBiomaterialsBioprintingDrug deliverySustainabilityTissue engineering

Identifiers

PMID39650072
PMCPMC11618173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.